Emma Eng | VP, GD&AI Development
Novo Nordisk

Emma Eng is Vice President of Global Data & AI, Development at Novo Nordisk, where she leads strategic implementation of artificial intelligence and data solutions for drug development. With over 15 years of experience working with digital in the life science industry she has worked with a wide range of different technologies spanning both manufacturing, drug development and regulatory affairs. Her extensive experience includes managing complex global programs and leading cross-functional teams across multiple international sites. She is an inclusive leader who is passionate about creating tangible business value, collaborating across the value chain and empowering people.